• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发热伴血小板减少综合征患者全身炎症反应综合征:患病率、特征及对预后的影响。

Systemic inflammatory response syndrome in patients with severe fever with thrombocytopenia syndrome: prevalence, characteristics, and impact on prognosis.

机构信息

Department of Infectious Disease, Zhongnan Hospital of Wuhan University, Wuhan, China.

Department of Infectious Diseases, Tongji Hospital, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Disease, Huazhong University of Science and Technology, Wuhan, China.

出版信息

BMC Infect Dis. 2024 Jan 30;24(1):149. doi: 10.1186/s12879-024-09026-4.

DOI:10.1186/s12879-024-09026-4
PMID:38291390
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10829256/
Abstract

BACKGROUND

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging zoonosis with a high fatality rate in China. Previous studies have reported that dysregulated inflammatory response is associated with disease pathogenesis and mortality in patients with SFTS. This investigation aimed to evaluate the prevalence and characteristics of systemic inflammatory response syndrome (SIRS), and its impact on prognosis.

METHODS

Data on demographic characteristics, comorbid conditions, clinical manifestations, laboratory parameters, and survival time of patients with SFTS were collected. Patients were divided into the non-SIRS and SIRS groups according to the presence of SIRS, then their clinical data were compared.

RESULTS

A total of 290 patients diagnosed with SFTS were retrospectively enrolled, including 126(43.4%) patients with SIRS. Patients in the non-survivor group had more prevalence of SIRS than patients in the survivor group (P < 0.001), and SIRS (adjusted OR 2.885, 95% CI 1.226-6.786; P = 0.005) was shown as an independent risk factor for prognosis of patients with SFTS. Compared with patients without SIRS, patients with SIRS had lower WBC and neutrophils counts, and fibrinogen levels, but higher AST, LDH, amylase, lipase, CK, CK-MB, troponin I, APTT, thrombin time, D-dimer, CRP, IL-6, SAA levels, and viral load. The cumulative survival rate of patients with SIRS was significantly lower than that of patients without SIRS. Patients with SIRS also showed a higher incidence of bacterial or fungal infections than patients without SIRS.

CONCLUSIONS

SIRS is highly frequent in patients with SFTS, and it is associated with high mortality.

摘要

背景

严重发热伴血小板减少综合征(SFTS)是一种在中国具有高病死率的新兴人畜共患病。先前的研究表明,失调的炎症反应与 SFTS 患者的发病机制和死亡率有关。本研究旨在评估全身炎症反应综合征(SIRS)的流行率和特征及其对预后的影响。

方法

收集了 SFTS 患者的人口统计学特征、合并症、临床表现、实验室参数和生存时间的数据。根据是否存在 SIRS 将患者分为非 SIRS 组和 SIRS 组,然后比较其临床数据。

结果

共回顾性纳入 290 例 SFTS 患者,其中 126 例(43.4%)患者存在 SIRS。非幸存者组中 SIRS 的发生率高于幸存者组(P<0.001),SIRS(调整后的 OR 2.885,95%CI 1.226-6.786;P=0.005)是 SFTS 患者预后的独立危险因素。与无 SIRS 的患者相比,SIRS 患者的白细胞和中性粒细胞计数、纤维蛋白原水平较低,但 AST、LDH、淀粉酶、脂肪酶、CK、CK-MB、肌钙蛋白 I、APTT、凝血酶时间、D-二聚体、CRP、IL-6、SAA 水平和病毒载量较高。SIRS 患者的累积生存率明显低于无 SIRS 患者。SIRS 患者的细菌或真菌感染发生率也高于无 SIRS 患者。

结论

SIRS 在 SFTS 患者中发生率较高,与高死亡率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed1/10829256/7eefb250ba65/12879_2024_9026_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed1/10829256/8c9445473850/12879_2024_9026_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed1/10829256/7eefb250ba65/12879_2024_9026_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed1/10829256/8c9445473850/12879_2024_9026_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed1/10829256/7eefb250ba65/12879_2024_9026_Fig2_HTML.jpg

相似文献

1
Systemic inflammatory response syndrome in patients with severe fever with thrombocytopenia syndrome: prevalence, characteristics, and impact on prognosis.发热伴血小板减少综合征患者全身炎症反应综合征:患病率、特征及对预后的影响。
BMC Infect Dis. 2024 Jan 30;24(1):149. doi: 10.1186/s12879-024-09026-4.
2
The AST/ALT Ratio (De Ritis Ratio) Represents an Unfavorable Prognosis in Patients in Early-Stage SFTS: An Observational Cohort Study.AST/ALT 比值(De Ritis 比值)反映了早期发热伴血小板减少综合征患者的不良预后:一项观察性队列研究。
Front Cell Infect Microbiol. 2022 Feb 8;12:725642. doi: 10.3389/fcimb.2022.725642. eCollection 2022.
3
Clinical characteristics and influencing factors of severe fever with thrombocytopenia syndrome complicated by viral myocarditis: a retrospective study.临床特征及影响因素的严重发热伴血小板减少综合征病毒性心肌炎:回顾性研究。
BMC Infect Dis. 2024 Feb 22;24(1):240. doi: 10.1186/s12879-024-09096-4.
4
Analysis of risk factors associated with fatal outcome among severe fever with thrombocytopenia syndrome patients from 2015 to 2019 in Shandong, China.2015 年至 2019 年中国山东严重发热伴血小板减少综合征患者死亡结局相关危险因素分析。
Eur J Clin Microbiol Infect Dis. 2022 Dec;41(12):1415-1420. doi: 10.1007/s10096-022-04506-4. Epub 2022 Oct 11.
5
Epidemiological and Clinical Characteristics of Severe Fever with Thrombocytopenia Syndrome in Southern Anhui Province, China, 2011-2020.中国安徽省南部地区 2011-2020 年严重发热伴血小板减少综合征的流行病学和临床特征。
Jpn J Infect Dis. 2022 Mar 24;75(2):133-139. doi: 10.7883/yoken.JJID.2021.391. Epub 2021 Aug 31.
6
Predictive risk score model for severe fever with thrombocytopenia syndrome mortality based on qSOFA and SIRS scoring system.基于 qSOFA 和 SIRS 评分系统的发热伴血小板减少综合征死亡的预测风险评分模型。
BMC Infect Dis. 2020 Aug 12;20(1):595. doi: 10.1186/s12879-020-05299-7.
7
Prevalence and clinical characteristics of increased pancreatic enzymes in patients with severe fever with thrombocytopenia syndrome.严重发热伴血小板减少综合征患者胰腺酶升高的患病率和临床特征。
PLoS Negl Trop Dis. 2023 Nov 9;17(11):e0011758. doi: 10.1371/journal.pntd.0011758. eCollection 2023 Nov.
8
Clinical feature of severe fever with thrombocytopenia syndrome (SFTS)-associated encephalitis/encephalopathy: a retrospective study.严重发热伴血小板减少综合征相关脑炎/脑病的临床特征:一项回顾性研究。
BMC Infect Dis. 2021 Sep 3;21(1):904. doi: 10.1186/s12879-021-06627-1.
9
Clinical characteristics and outcomes of acute kidney injury in patients with severe fever with thrombocytopenia syndrome.发热伴血小板减少综合征患者急性肾损伤的临床特征及预后
Front Microbiol. 2023 Sep 13;14:1236091. doi: 10.3389/fmicb.2023.1236091. eCollection 2023.
10
Clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) sepsis and non-SFTS sepsis.发热伴血小板减少综合征(SFTS)脓毒症与非SFTS脓毒症的临床特征。
Mol Immunol. 2023 Dec;164:1-6. doi: 10.1016/j.molimm.2023.10.006. Epub 2023 Oct 20.

引用本文的文献

1
Prediction of Mortality by Clinical Laboratory Parameters in Severe Fever with Thrombocytopenia Syndrome: A Meta-Analysis.通过临床实验室参数预测发热伴血小板减少综合征患者的死亡率:一项Meta分析
Trop Med Infect Dis. 2025 Jul 9;10(7):193. doi: 10.3390/tropicalmed10070193.
2
Role of Ischemia/Reperfusion and Oxidative Stress in Shock State.缺血/再灌注及氧化应激在休克状态中的作用
Cells. 2025 May 30;14(11):808. doi: 10.3390/cells14110808.
3
Bronchoalveolar lavage cytokine profile and clinical features as risk predictors of plastic bronchitis in children with Mycoplasma pneumoniae pneumonia.

本文引用的文献

1
Pulmonary infection in patients with severe fever with thrombocytopenia syndrome: A multicentre observational study.发热伴血小板减少综合征患者的肺部感染:一项多中心观察性研究。
J Med Virol. 2023 Apr;95(4):e28712. doi: 10.1002/jmv.28712.
2
Coinfections in hospitalized patients with severe fever with thrombocytopenia syndrome: A retrospective study.发热伴血小板减少综合征住院患者的合并感染:一项回顾性研究。
J Med Virol. 2022 Dec;94(12):5933-5942. doi: 10.1002/jmv.28093. Epub 2022 Sep 3.
3
Associated microbiota and treatment of severe fever with thrombocytopenia syndrome complicated with infections.
支气管肺泡灌洗细胞因子谱及临床特征作为肺炎支原体肺炎患儿塑料支气管炎风险预测指标
Ital J Pediatr. 2025 Jun 7;51(1):175. doi: 10.1186/s13052-025-02041-4.
4
Longitudinal analysis of cytokine dynamics in severe fever with thrombocytopenia syndrome patients - High-incidence regions of China (2010-2023).中国(2010 - 2023年)重症发热伴血小板减少综合征患者细胞因子动态的纵向分析——高发地区
Biosaf Health. 2025 Mar 26;7(2):83-93. doi: 10.1016/j.bsheal.2025.03.005. eCollection 2025 Apr.
5
Clinical characteristics and outcomes of disseminated intravascular coagulation in patients with severe fever with thrombocytopenia syndrome.严重发热伴血小板减少综合征患者弥散性血管内凝血的临床特征及预后
BMC Infect Dis. 2025 Apr 11;25(1):508. doi: 10.1186/s12879-025-10900-y.
6
Clinical significance of C-reactive protein in patients with severe fever with thrombocytopenia syndrome.严重发热伴血小板减少综合征患者中C反应蛋白的临床意义
J Rural Med. 2025 Apr;20(2):66-70. doi: 10.2185/jrm.2024-059. Epub 2025 Apr 1.
相关微生物群与发热伴血小板减少综合征合并感染的治疗。
J Med Virol. 2022 Dec;94(12):5916-5921. doi: 10.1002/jmv.28059. Epub 2022 Aug 15.
4
Clinical laboratory parameters and fatality of Severe fever with thrombocytopenia syndrome patients: A systematic review and meta-analysis.严重发热伴血小板减少综合征患者的临床实验室参数与病死率:系统评价和荟萃分析。
PLoS Negl Trop Dis. 2022 Jun 17;16(6):e0010489. doi: 10.1371/journal.pntd.0010489. eCollection 2022 Jun.
5
Clinical features of severe fever with thrombocytopenia syndrome and analysis of risk factors for mortality.严重发热伴血小板减少综合征的临床特征及死亡危险因素分析。
BMC Infect Dis. 2021 Dec 14;21(1):1253. doi: 10.1186/s12879-021-06946-3.
6
The 'cytokine storm': molecular mechanisms and therapeutic prospects.细胞因子风暴:分子机制与治疗前景。
Trends Immunol. 2021 Aug;42(8):681-705. doi: 10.1016/j.it.2021.06.001. Epub 2021 Jul 1.
7
Changes in peripheral blood cytokines in patients with severe fever with thrombocytopenia syndrome.严重发热伴血小板减少综合征患者外周血细胞因子的变化。
J Med Virol. 2021 Aug;93(8):4704-4713. doi: 10.1002/jmv.26877. Epub 2021 Mar 11.
8
Predictive risk score model for severe fever with thrombocytopenia syndrome mortality based on qSOFA and SIRS scoring system.基于 qSOFA 和 SIRS 评分系统的发热伴血小板减少综合征死亡的预测风险评分模型。
BMC Infect Dis. 2020 Aug 12;20(1):595. doi: 10.1186/s12879-020-05299-7.
9
Severe Fever with Thrombocytopenia Syndrome, Japan, 2013-2017.严重发热伴血小板减少综合征,日本,2013-2017 年。
Emerg Infect Dis. 2020 Apr;26(4):692-699. doi: 10.3201/eid2604.191011.
10
Analysis of Severe Fever With Thrombocytopenia Syndrome in Critical Ill Patients in Central China.华中地区危重症严重发热伴血小板减少综合征患者分析。
Shock. 2020 Oct;54(4):451-457. doi: 10.1097/SHK.0000000000001527.